Amiodarone Used Alone or in Combination with Propranolol: A Very Effective Therapy for Tachyarrhythmias in Infants and Children View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-11

AUTHORS

F. Drago, A. Mazza, P. Guccione, A. Mafrici, G. Di Liso, P. Ragonese

ABSTRACT

The aim of the study was to evaluate the efficacy of amiodarone used alone or in combination with propranolol in infants and children affected by life-threatening or drug-resistant tachyarrhythmias. The study included 27 children (median age 3 months), affected by life-threatening and/or drug-resistant supraventricular or ventricular tachyarrhythmias. The loading dose of amiodarone was 10-20 mg/kg/day and the maintenance dose ranged between 3 and 20 mg/kg/day. When amiodarone was ineffective, propranolol was added at a dosage of 2-4 mg/kg/day. The study population was divided into two groups: group A was composed of patients <1 year and group B of patients >1 year. The effectiveness of the therapy was assessed by clinical evaluation, Holter monitoring, exercise testing, and, in patients with reentry tachycardias, electrophysiological testing. Amiodarone used alone was effective or partially effective in 4/14 (28%) patients in group A and in 11/13 (85%) patients in group B (p < 0.006). Among amiodarone-resistant patients, the combined therapy with propranolol was effective in 8/10 patients in group A and 2/2 patients in group B. Therefore, amiodarone used alone or in combination with propranolol was effective in 25/27 (93%) patients. During the follow-up (20.5 +/- 13 months) there were no arrhythmic effects but side effects were noted in 5/27 (18.5%) patients. Amiodarone seems to be an effective drug in the control of the life-threatening and/or drug-resistant supraventricular and ventricular tachyarrhythmias in children. The addition of propranolol can significantly enhance the success rate of this class III drug, especially in the treatment of reentry tachycardias due to accessory pathways. More... »

PAGES

445-449

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002469900353

DOI

http://dx.doi.org/10.1007/s002469900353

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042314713

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9770567


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amiodarone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Arrhythmia Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Electrocardiography, Ambulatory", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant, Newborn", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propranolol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tachycardia, Supraventricular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tachycardia, Ventricular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Bambino Ges\u00f9 Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414125.7", 
          "name": [
            "Pediatric Cardiology Department, Bambino Ges\u00f9 Hospital, Piazza Sant'Onofrio 4, 00165 Rome, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Drago", 
        "givenName": "F.", 
        "id": "sg:person.0715204612.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715204612.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale di Santo Spirito", 
          "id": "https://www.grid.ac/institutes/grid.415245.3", 
          "name": [
            "Department of Cardiology, Santo Spirito Hospital, Lungotevere in Sassia 1, Rome, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mazza", 
        "givenName": "A.", 
        "id": "sg:person.01325757554.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325757554.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bambino Ges\u00f9 Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414125.7", 
          "name": [
            "Pediatric Cardiology Department, Bambino Ges\u00f9 Hospital, Piazza Sant'Onofrio 4, 00165 Rome, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guccione", 
        "givenName": "P.", 
        "id": "sg:person.0770716037.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770716037.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bambino Ges\u00f9 Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414125.7", 
          "name": [
            "Pediatric Cardiology Department, Bambino Ges\u00f9 Hospital, Piazza Sant'Onofrio 4, 00165 Rome, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mafrici", 
        "givenName": "A.", 
        "id": "sg:person.0650466654.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650466654.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bambino Ges\u00f9 Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414125.7", 
          "name": [
            "Pediatric Cardiology Department, Bambino Ges\u00f9 Hospital, Piazza Sant'Onofrio 4, 00165 Rome, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Di Liso", 
        "givenName": "G.", 
        "id": "sg:person.01236435503.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236435503.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bambino Ges\u00f9 Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414125.7", 
          "name": [
            "Pediatric Cardiology Department, Bambino Ges\u00f9 Hospital, Piazza Sant'Onofrio 4, 00165 Rome, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ragonese", 
        "givenName": "P.", 
        "id": "sg:person.01070156170.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070156170.26"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0002-8703(80)90214-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010508625"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-8703(92)90405-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014427679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1113/jphysiol.1989.sp017721", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025607556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-8703(95)90396-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029003689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.75.3.542", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041256499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/hrt.56.3.278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045842022"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-11", 
    "datePublishedReg": "1998-11-01", 
    "description": "The aim of the study was to evaluate the efficacy of amiodarone used alone or in combination with propranolol in infants and children affected by life-threatening or drug-resistant tachyarrhythmias. The study included 27 children (median age 3 months), affected by life-threatening and/or drug-resistant supraventricular or ventricular tachyarrhythmias. The loading dose of amiodarone was 10-20 mg/kg/day and the maintenance dose ranged between 3 and 20 mg/kg/day. When amiodarone was ineffective, propranolol was added at a dosage of 2-4 mg/kg/day. The study population was divided into two groups: group A was composed of patients <1 year and group B of patients >1 year. The effectiveness of the therapy was assessed by clinical evaluation, Holter monitoring, exercise testing, and, in patients with reentry tachycardias, electrophysiological testing. Amiodarone used alone was effective or partially effective in 4/14 (28%) patients in group A and in 11/13 (85%) patients in group B (p < 0.006). Among amiodarone-resistant patients, the combined therapy with propranolol was effective in 8/10 patients in group A and 2/2 patients in group B. Therefore, amiodarone used alone or in combination with propranolol was effective in 25/27 (93%) patients. During the follow-up (20.5 +/- 13 months) there were no arrhythmic effects but side effects were noted in 5/27 (18.5%) patients. Amiodarone seems to be an effective drug in the control of the life-threatening and/or drug-resistant supraventricular and ventricular tachyarrhythmias in children. The addition of propranolol can significantly enhance the success rate of this class III drug, especially in the treatment of reentry tachycardias due to accessory pathways.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s002469900353", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1091102", 
        "issn": [
          "0172-0643", 
          "1432-1971"
        ], 
        "name": "Pediatric Cardiology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "Amiodarone Used Alone or in Combination with Propranolol: A Very Effective Therapy for Tachyarrhythmias in Infants and Children", 
    "pagination": "445-449", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c990524329b47147f2f9c27df75e62323820cbb8fc7d8bbce4ee2dea65dad226"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9770567"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8003849"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002469900353"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042314713"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002469900353", 
      "https://app.dimensions.ai/details/publication/pub.1042314713"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T23:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000515.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs002469900353"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002469900353'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002469900353'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002469900353'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002469900353'


 

This table displays all metadata directly associated to this object as RDF triples.

197 TRIPLES      21 PREDICATES      53 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002469900353 schema:about N1a326175302841f2b24a873c2a079682
2 N1d9b69ca870043dfb0faecb51b1048cd
3 N2d979d0ab7c7465ba7d20b0e53bb880e
4 N3800b75e2fd540479ba45abeb9410317
5 N489041e082f44ec2a17c6856f49bf098
6 N613eb544ba6f4a4b8b2da41aedd70c9c
7 N6bc11cae44d9408786799bd6a2941405
8 N752e9486b4de442d82c38658c1192b35
9 N7970e213c55849e1a0218cda3877d7d3
10 N8a11afa7a4cb487ab3f3a2739453720d
11 Na52b8da620f545af92868933da10430e
12 Na8a04a59722a4f7ba4462f655e4bba78
13 Nad0c7a91cd494a8797658f7a64d74c22
14 Nc06d8c53e62043f08ac7572055f28179
15 Nc587a12a5ae9418bb83af2ca741064d8
16 Nccaddadca7374b3a8f1f877eb05cc7ae
17 Ne7f6437259c841e1b8faca1e6157ce53
18 Nf74d06e3fe594de79f56fb632daaf1cb
19 anzsrc-for:11
20 anzsrc-for:1117
21 schema:author Nf443ba55059d4734a043e2c815a4f902
22 schema:citation https://doi.org/10.1016/0002-8703(80)90214-8
23 https://doi.org/10.1016/0002-8703(92)90405-k
24 https://doi.org/10.1016/0002-8703(95)90396-8
25 https://doi.org/10.1113/jphysiol.1989.sp017721
26 https://doi.org/10.1136/hrt.56.3.278
27 https://doi.org/10.1161/01.cir.75.3.542
28 schema:datePublished 1998-11
29 schema:datePublishedReg 1998-11-01
30 schema:description The aim of the study was to evaluate the efficacy of amiodarone used alone or in combination with propranolol in infants and children affected by life-threatening or drug-resistant tachyarrhythmias. The study included 27 children (median age 3 months), affected by life-threatening and/or drug-resistant supraventricular or ventricular tachyarrhythmias. The loading dose of amiodarone was 10-20 mg/kg/day and the maintenance dose ranged between 3 and 20 mg/kg/day. When amiodarone was ineffective, propranolol was added at a dosage of 2-4 mg/kg/day. The study population was divided into two groups: group A was composed of patients <1 year and group B of patients >1 year. The effectiveness of the therapy was assessed by clinical evaluation, Holter monitoring, exercise testing, and, in patients with reentry tachycardias, electrophysiological testing. Amiodarone used alone was effective or partially effective in 4/14 (28%) patients in group A and in 11/13 (85%) patients in group B (p < 0.006). Among amiodarone-resistant patients, the combined therapy with propranolol was effective in 8/10 patients in group A and 2/2 patients in group B. Therefore, amiodarone used alone or in combination with propranolol was effective in 25/27 (93%) patients. During the follow-up (20.5 +/- 13 months) there were no arrhythmic effects but side effects were noted in 5/27 (18.5%) patients. Amiodarone seems to be an effective drug in the control of the life-threatening and/or drug-resistant supraventricular and ventricular tachyarrhythmias in children. The addition of propranolol can significantly enhance the success rate of this class III drug, especially in the treatment of reentry tachycardias due to accessory pathways.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf N7febca0d72514c06b44fe86299d3c979
35 Nbdc5ac1886e941fe9687fc8dcfa62956
36 sg:journal.1091102
37 schema:name Amiodarone Used Alone or in Combination with Propranolol: A Very Effective Therapy for Tachyarrhythmias in Infants and Children
38 schema:pagination 445-449
39 schema:productId N6f078b8c256c437ca536eb7089092973
40 N88474102ee3a41ef88bfb85907a65fb6
41 N9e8f781474034d569a81be8396146d38
42 Naae17655feff4fccbc6419c5872ccbe1
43 Nfac1fa372c4549b0a291b976c466c6f7
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042314713
45 https://doi.org/10.1007/s002469900353
46 schema:sdDatePublished 2019-04-10T23:25
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher N21d785f287304197b945e6db32c98872
49 schema:url http://link.springer.com/10.1007%2Fs002469900353
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N1a326175302841f2b24a873c2a079682 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Drug Therapy, Combination
55 rdf:type schema:DefinedTerm
56 N1d9b69ca870043dfb0faecb51b1048cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Amiodarone
58 rdf:type schema:DefinedTerm
59 N1fcb21330b214097b5ac3d3e7d45989f rdf:first sg:person.01236435503.68
60 rdf:rest Ne28d7151d72f4eb3ba85472b67714a44
61 N21d785f287304197b945e6db32c98872 schema:name Springer Nature - SN SciGraph project
62 rdf:type schema:Organization
63 N2d979d0ab7c7465ba7d20b0e53bb880e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Infant, Newborn
65 rdf:type schema:DefinedTerm
66 N3800b75e2fd540479ba45abeb9410317 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Propranolol
68 rdf:type schema:DefinedTerm
69 N3d217589e1d940d3ba6b79e875e10c12 rdf:first sg:person.0650466654.39
70 rdf:rest N1fcb21330b214097b5ac3d3e7d45989f
71 N489041e082f44ec2a17c6856f49bf098 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Humans
73 rdf:type schema:DefinedTerm
74 N613eb544ba6f4a4b8b2da41aedd70c9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Tachycardia, Supraventricular
76 rdf:type schema:DefinedTerm
77 N6bc11cae44d9408786799bd6a2941405 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Adolescent
79 rdf:type schema:DefinedTerm
80 N6f078b8c256c437ca536eb7089092973 schema:name readcube_id
81 schema:value c990524329b47147f2f9c27df75e62323820cbb8fc7d8bbce4ee2dea65dad226
82 rdf:type schema:PropertyValue
83 N752e9486b4de442d82c38658c1192b35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Drug Administration Schedule
85 rdf:type schema:DefinedTerm
86 N7970e213c55849e1a0218cda3877d7d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Tachycardia, Ventricular
88 rdf:type schema:DefinedTerm
89 N7febca0d72514c06b44fe86299d3c979 schema:issueNumber 6
90 rdf:type schema:PublicationIssue
91 N88474102ee3a41ef88bfb85907a65fb6 schema:name nlm_unique_id
92 schema:value 8003849
93 rdf:type schema:PropertyValue
94 N8a11afa7a4cb487ab3f3a2739453720d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Treatment Outcome
96 rdf:type schema:DefinedTerm
97 N9e8f781474034d569a81be8396146d38 schema:name dimensions_id
98 schema:value pub.1042314713
99 rdf:type schema:PropertyValue
100 Na52b8da620f545af92868933da10430e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Female
102 rdf:type schema:DefinedTerm
103 Na8a04a59722a4f7ba4462f655e4bba78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Male
105 rdf:type schema:DefinedTerm
106 Naae17655feff4fccbc6419c5872ccbe1 schema:name doi
107 schema:value 10.1007/s002469900353
108 rdf:type schema:PropertyValue
109 Nad0c7a91cd494a8797658f7a64d74c22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Child
111 rdf:type schema:DefinedTerm
112 Nb1d25c522cc64ed0ab19e0de2a49d0ee rdf:first sg:person.01325757554.19
113 rdf:rest Ne1ea6380282342a291e46844a9bab796
114 Nbdc5ac1886e941fe9687fc8dcfa62956 schema:volumeNumber 19
115 rdf:type schema:PublicationVolume
116 Nc06d8c53e62043f08ac7572055f28179 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Dose-Response Relationship, Drug
118 rdf:type schema:DefinedTerm
119 Nc587a12a5ae9418bb83af2ca741064d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Electrocardiography, Ambulatory
121 rdf:type schema:DefinedTerm
122 Nccaddadca7374b3a8f1f877eb05cc7ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Infant
124 rdf:type schema:DefinedTerm
125 Ne1ea6380282342a291e46844a9bab796 rdf:first sg:person.0770716037.31
126 rdf:rest N3d217589e1d940d3ba6b79e875e10c12
127 Ne28d7151d72f4eb3ba85472b67714a44 rdf:first sg:person.01070156170.26
128 rdf:rest rdf:nil
129 Ne7f6437259c841e1b8faca1e6157ce53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Anti-Arrhythmia Agents
131 rdf:type schema:DefinedTerm
132 Nf443ba55059d4734a043e2c815a4f902 rdf:first sg:person.0715204612.40
133 rdf:rest Nb1d25c522cc64ed0ab19e0de2a49d0ee
134 Nf74d06e3fe594de79f56fb632daaf1cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Child, Preschool
136 rdf:type schema:DefinedTerm
137 Nfac1fa372c4549b0a291b976c466c6f7 schema:name pubmed_id
138 schema:value 9770567
139 rdf:type schema:PropertyValue
140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
141 schema:name Medical and Health Sciences
142 rdf:type schema:DefinedTerm
143 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
144 schema:name Public Health and Health Services
145 rdf:type schema:DefinedTerm
146 sg:journal.1091102 schema:issn 0172-0643
147 1432-1971
148 schema:name Pediatric Cardiology
149 rdf:type schema:Periodical
150 sg:person.01070156170.26 schema:affiliation https://www.grid.ac/institutes/grid.414125.7
151 schema:familyName Ragonese
152 schema:givenName P.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070156170.26
154 rdf:type schema:Person
155 sg:person.01236435503.68 schema:affiliation https://www.grid.ac/institutes/grid.414125.7
156 schema:familyName Di Liso
157 schema:givenName G.
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236435503.68
159 rdf:type schema:Person
160 sg:person.01325757554.19 schema:affiliation https://www.grid.ac/institutes/grid.415245.3
161 schema:familyName Mazza
162 schema:givenName A.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325757554.19
164 rdf:type schema:Person
165 sg:person.0650466654.39 schema:affiliation https://www.grid.ac/institutes/grid.414125.7
166 schema:familyName Mafrici
167 schema:givenName A.
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650466654.39
169 rdf:type schema:Person
170 sg:person.0715204612.40 schema:affiliation https://www.grid.ac/institutes/grid.414125.7
171 schema:familyName Drago
172 schema:givenName F.
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715204612.40
174 rdf:type schema:Person
175 sg:person.0770716037.31 schema:affiliation https://www.grid.ac/institutes/grid.414125.7
176 schema:familyName Guccione
177 schema:givenName P.
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770716037.31
179 rdf:type schema:Person
180 https://doi.org/10.1016/0002-8703(80)90214-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010508625
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1016/0002-8703(92)90405-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1014427679
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/0002-8703(95)90396-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029003689
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1113/jphysiol.1989.sp017721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025607556
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1136/hrt.56.3.278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045842022
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1161/01.cir.75.3.542 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041256499
191 rdf:type schema:CreativeWork
192 https://www.grid.ac/institutes/grid.414125.7 schema:alternateName Bambino Gesù Children's Hospital
193 schema:name Pediatric Cardiology Department, Bambino Gesù Hospital, Piazza Sant'Onofrio 4, 00165 Rome, Italy, IT
194 rdf:type schema:Organization
195 https://www.grid.ac/institutes/grid.415245.3 schema:alternateName Ospedale di Santo Spirito
196 schema:name Department of Cardiology, Santo Spirito Hospital, Lungotevere in Sassia 1, Rome, Italy, IT
197 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...